Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions

Non-alcoholic fatty liver disease (NAFLD) is a disorder of excessive fat accumulation in the liver, known as steatosis, without alcohol overconsumption. NAFLD can either manifest as simple steatosis or steatohepatitis, known as non-alcoholic steatohepatitis (NASH), which is accompanied by inflammati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Life sciences (1973) 2021-04, Vol.271, p.119220, Article 119220
Hauptverfasser:	Gerges, Samar H., Wahdan, Sara A., Elsherbiny, Doaa A., El-Demerdash, Ebtehal
Format:	Artikel
Sprache:	eng
Schlagworte:	Adipose tissue Curcumin - pharmacology Curcumin - therapeutic use Diagnosis Diagnostic systems Diagnostic tests Diet Fatty liver Fibrosis Genetic factors Health risks Hepatocellular carcinoma Humans Insulin Insulin resistance Insulin Resistance - physiology Liver Liver - drug effects Liver - physiopathology Liver diseases Liver Transplantation - methods Management Metabolic disorders Metabolic Syndrome - diagnosis Metabolic Syndrome - physiopathology Metabolic Syndrome - therapy Metabolism Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - physiopathology Non-alcoholic Fatty Liver Disease - therapy Non-alcoholic steatohepatitis Obesity - diagnosis Obesity - physiopathology Obesity - therapy Pandemics Plant Preparations - pharmacology Plant Preparations - therapeutic use Resveratrol - pharmacology Resveratrol - therapeutic use Risk analysis Risk Factors Steatosis Therapeutic applications
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!